Monopar Therapeutics Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 5 - Stock Incentive Plan (Tables)

Note 5 - Stock Incentive Plan (Tables)

9 Months Ended

Sep. 30, 2026

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

		*Options Outstanding*
		*Number of Shares Subject to Options*				*Weighted-Average Exercise Price*
Balances at December 31, 2025			616,555			$	30.77
Granted⁽¹⁾			156,812				90.20
Forfeited⁽²⁾⁽³⁾			(10,168	)			53.81
Exercised			(42,245	)			21.11
Balances at September 30, 2026			720,954				43.94
Unvested options outstanding expected to vest⁽³⁾			279,659				68.22

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

Exercise Prices		Number of Shares Subject to Options Outstanding				Weighted-Average Remaining Contractual Term in Years				Number of Shares Subject to Options Fully Vested and Exercisable				Weighted-Average Remaining Contractual Term in Years
$0.00 - $25.00			183,878				4.91				174,916				4.80
$25.01 - $50.00			310,213				6.48				217,724				5.64
$50.01 - $75.00			82,870				7.78				29,894				4.85
$75.01 - $100.00			57,293				9.07				17,844				8.45
$100.01 - $125.00			86,700				9.84				917				9.04
			720,954								441,295

Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

						*Weighted- Average*
						*Grant Date*
		*Restricted*				*Fair Value*
		*Stock Units*				*per Unit*
Unvested balance at December 31, 2025			175,634			$	48.88
Granted⁽¹⁾			—				—
Vested			(45,527	)			41.50
Forfeited			(1,455	)			21.11
Unvested Balance at September 30, 2026			128,652			$	51.81

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]

		*Three Months Ended September 30,*								*Nine Months Ended September 30,*
		*2026*				*2025*				*2026*				*2025*

Stock options granted			91,500				22,500				156,812				248,381
Weighted-average grant date fair value per share		$	105.25			$	37.52			$	82.45			$	29.98
Fair value of shares vested		$	1,165,623			$	810,749			$	2,778,877			$	2,513,309